Thrombotic microangiopathy in a patient with a genetic form of thrombofilia as a factor of the risk of progression of IgA-nephropathy


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article presents a clinical observation illustrating the possibility of a severe course of IgA-nephropathy when it combines with thrombotic microangiopathy (ТМА). The reasons for the development of TMA are discussed. The features of this clinical observation also include malignant hypertension (MHT). The possible mechanisms of this unusual course of IgA-nephropathy, which is generally a benign disease, are discussed in the article

Full Text

Restricted Access

About the authors

D. E Rodriges

FSAEI HE "First Moscow State Medical University n.a. I.M. Sechenov” of RMH

Email: neicosha@yandex.ru
Postgraduate Student at the Department of Internal, Occupational Diseases and Pulmonology of the Public Health Faculty

L. A Bobrova

FSAEI HE "First Moscow State Medical University n.a. I.M. Sechenov” of RMH

PhD in Medical Sciences, Senior Researcher at the Department of Nephrology

N. L Kozlovskaya

FSAEI HE "First Moscow State Medical University n.a. I.M. Sechenov” of RMH; Clinic of Nephrology, Internal and Occupational Diseases n.a. E.M. Tareev UCH № 3

Doctor of Medical Sciences, Professor at the Department of Internal, Occupational Diseases and Pulmonology of the Public Health Faculty

E. S Stolyarevich

SBEI HPE "Moscow State Medical Stomatological University n.a. A.i. Evdokimov" of RMH; SBHCI "City Clinical Hospital № 52" of Moscow Healthcare Department

Doctor at the Pathoanatomical Department of the SBHCI "City Clinical Hospital № 52" of Moscow Healthcare Department, Professor at the Department of Nephrology FAPE FSBEI HE "MSMSU n.a. A.I. Evdokimov"

References

  1. Шилов Е.М., Смирнов А.В., Козловская Н.Л., Нефрология. Клинические рекомендации. М.,2016.
  2. Floege J., Moura I. C., Daha M. R. New insights into the pathogenesis of IgA nephropathy. Semin. Immunopathol. 2014; 4: 431-442.
  3. Mohey H. Natural History of Primary IgA. 2008; 1: 4-9.
  4. Nasri H., Mubarak М. Significance of vasculopathy in IgA nephropathy patients with regard to Oxford classification and immunostaining findings: a single center experience. J. Ren. Inj. Prev. 2013; 2: 41-45.
  5. El Karoui K. Hill G.S., Karras A., Jacquot C, Moulonguet L., Kourilsky O., Frémeaux-Bacchi V., Delahousse M., Duong Van Huyen J.P., Loupy A., Bruneval P., Nochy D.A Clinicopathologic Study of Thrombotic Microangiopathy in IgA Nephropathy. 2012; 1: 137-148.
  6. Козловская Н.Л., Акаева М.И., Столяревич Е.С., Боброва Л.А., Бондаренко Т.В. Тромботическая микроангиопатия, ассоциированная со злокачественной артериальной гипертензией. Клиническая нефрология. 2017; 1: 49-56.
  7. Sucker C., Hetzel G.R., Farokhzad F., Dahhan F., Schmitz M., Kurschat C., Grabensee B., Maruhn-Debowski B., Zotz R., Scharf R. Association of genotypes of thrombin-activatable fibrinolysis inhibitors with thrombotic microangiopathies - a pilot study. Nephrol. Dial. Transplant. 2007; 5: 1347-1350.
  8. Sucker C., Kurschat C., Hetzel G.R., Grabensee B., Maruhn-Debowski B., Loncar R., Ostojic L., Scharf R.E., Zotz R.B. The G1691A mutation of the factor V gene (factor V Leiden) and the G20210A mutation of the prothrombin gene as risk factors in thrombotic microangiopathies. Clin. Appl. Thromb. Hemost. 2009; 3: 360-363.
  9. Sucker C., Schmitz M., Hetzel G.R., Grabensee B., Maruhn-Debowski B., Ostojic L., Scharf R.E., Zotz R.B. Are prothrombotic variants of platelet glycoprotein receptor polymorphisms involved in the pathogenesis of thrombotic microangiopathies ? Clin. Appl. Thromb. Hemost. 2009; 4: 402-407.
  10. Sucker C., Farokhzad F., Kurschat C., Grabensee B., Scharf R.E., Zotz R.B., Maruhn-Debowski B., Hetzel G.R. The homozygous Leu variant of the Factor XIII Val34 Leu polymorphism as a risk factor for the manifestation of thrombotic microangiopathies. Clin. Appl. Thromb. Hemost. 2009; 2: 197-200.
  11. Bu F., Maga T., Meyer N.C., Wang K., Thomas C.P., Nester C.M., Smith R.J. Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome. J. Am. Soc. Nephrol. 2014; 1: 55-64.
  12. Sucker C., Kurschat C., Farokhzad F., Hetzel G.R., Grabensee B., Maruhn-Debowski B., Loncar R., Scharf R.E., Zotz R.B. The TT genotype of the C677T polymorphism in the methylentetrahydrofolate reductase as a risk factor in thrombotic microangiopathies: results from a pilot study. Clin. Appl. Thromb. Hemost. 2009; 3: 283-288.
  13. Боброва Л.А., Козловская Н.Л., Шкарупо В.В., Варшавский В.А. Влияние генетической формы тромбофилии на клинико-морфологические проявления и характер течения хронического гломерулонефрита. Нефрология и диализ. 2010; 1: 25-33.
  14. Козловская Н.Л., Боброва Л.А., Шкарупо В.В., Варшавский В.А. Клиникоморфологические особенности поражения почек у больных с генетической формой тромбофилии. Терапевтический архив. 2009; 8: 30-36.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies